A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

T cells are an elite fighting force of the immune system, seeking out and destroying diseased cells. But in a prolonged ...

Researchers say approach could be useful for both initial treatment of bladder cancer as well as treatment refractory subsets of tumors.

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

Researchers at Mayo Clinic have uncovered a previously hidden step in how the immune system prepares to fight cancer, a ...

Cancer cells that disseminate from a tumor can enter a period of dormancy that may persist from months to decades before metastasis. Efforts to improve adjuvant therapy to remove residual cancer cells ...

But in the case of cancer, this guardian exchanges its sugar coat armour for shorter sugar chains and so turns into a traitor ...

Researchers found that loss of GATA6 reprograms colorectal cancer cells into flexible, fetal-like states that can spread to ...